Final data from the COMPANION trial shows that cardiac resynchronization therapy (CRT) significantly improves survival and reduces hospitalizations for certain patients with congestive heart failure. These benefits are seen even in patients who are already on optimal drug therapy for heart failure. Read more about CRT for heart failure here.
Comments
No comments yet. Leave a Comment
